ThrombosisRx
Terms
undefined, object
copy deck
- actiated plateles accelerate the coagulation pathway or slow it down?
- accelerate
- the coag proteins like thrombin contribute to platelet aggregation T or F
- True
-
list the events in order...
a. aggregation
b. platelet adhesion to the site of injury
c. activation of platelet surface receptors and release of platelet products - b, c, a
-
GPIa/IIa to collagen and GPIb to von Willibrand factor describe which process?
a. platelet adhesion to the site of injury
b. activation of platelet surface receptors
c. aggregation - a
-
ADP serotonin TXA2 are ..
a. involved in activation of platelet surface receptors and release of platelet products
b. aggregation
c. platelet adhesion to the site of injury - a.
- that receptor does thienopyridine block?
- P2Y
-
aspirin blocks ...
a. COX1
b. P2Y receptor
c. your mom
d. GPIIb/IIIa - a. cox 1
- what is the moa of dipyridamole?
- decrease cAMP
- what is the mechanism of action of ASA (aspirin)
- irreversible acetylates cox1 and inhibits the conversion of arachidonic acid to thromboxane TXA2 in platelets
-
true of false:
asa does not inhibit TXA2 synthesis and has tons and tons of effect on other factors that could initiate platelets activation and aggregation -
false.
asa only inhibs TXA synthesis and has no effect on other factors that could initiate platelets activation and aggregtaion - what is an adverse effect of Aspirin
- dyspepsia, nausea, gi bleed, hemorrhagic strokes, allergic rxn, asthma exacerbation and gout
- name a thienopyridine
- clopidogrel, prasugrel, ticopidine, ticagrelor
-
the primary indications of thienopyridines are...
a. ACS, percutaneous coronary interventions, unstable angina, recent MI with or without ST-elevation
b. CHF
c. prostetic heart valves - a. ACS, percutenous coronary interventions, unstable angina, recent mi with or with out st elevation
- what is a side effect of clopidogrel (other drugs in its class are prasurgrel, ticlopidine, ticagrelor)
- bleeding, dyspepsia diarrhea, neutropenia and thrombocytopenic purpura (with tilopidine)
- what are two classes of inhibitors of GP IIB/IIIa
-
abciximab
tirofiban and eptifibatide - what drug, used in combo with warfarin, is used to inhibit formation of thromboemoli from prostetic valves?
- dipyridamole
- What dual antiplatelet therapy is the cornerstone of treatment to prevent thrombotic complications of ACS and PCI
- aspirin and clopidogrel
- what would be a good combination for triple anti platelet therapy. slide 14 10 am jan 25
- asa, clopidogrel and eptifibatide, without anticoag therapy
- what kind of drug do u incorporate to reduce major and minor adverse events in percutaneous coronary intervention that leads to decreased bleeding complications?`
- eptifibatide based pharmacotherapy
- anti coag drugs/anti thrombin drugs MOA
- bind to antithrombin II and exposes its active site for more rapid inactivation of thrombin
- what are the toxicities assc'd with heparin
-
bleeding allergy alopecia osteoperosis
heparin induced thrombocytopenia - if a patient has active bleeding and hemophilia intracranial hemorrhage or advance liver or renal disease should you give heparin?
- no
- what drug for a heparin OD
- protamine sulfate
-
what are direct thrombin inhibitor drugs?
a. hirudin and bivalirudin
b. argatron and melagatran
c. zyrtec
c. propranolo - a and b
- who are direct thrombin inhibitors mostly indicated for?
- pts with HIT and venous thromboembolism
- name two anticoagulant drugs that are orally effective
- warfarin and coumarin
- what is the MOA of warfarin and coumarin
-
Antagonize the vitamin K-dependent
gamma-carboxylation of glutamate resideus
in prothrombin, factors VII, IX, and X
as well as endogenous anti-coagulant
proteins C and S. - what are the toxicities of warfarin and coumarin
-
bleeding and many drug interactions
crosses placenta and causes birthdefects - what do u give to pts who OD or warfarin
- vit K
-
streptokinase is...
a. a antidepressant
b. beta blocker
c. fibrinolytic (thrombolytic) drug
d. anticoagulant - c. fibrinolytic
- what kinda drug is anistreplase?
- fibrinolytic (streptokinase)
-
tissue plasminogen activators are
a. anticoag drugs
b. anti depressants
c. ca channel blockers
d. fibrinolytic ddrugs - d. fibrinolytic
-
which tissue plasminogen activator has a five min half life
alteplasse, retaplase or tenecteplase? - alteplase
-
urokinase is...
a. fibrinolytic
b. thrombolytic
c. ca channel blocker
d. na channel blocker - a and b. its the same thing
-
what is the mechanism of fibrinolytic action
-
SK and tPA bind to plasminogen to release the serine
protease, plasmin, which in turn breaks apart the thrombus
(fibrin molecules).
- what does excess plasmin protease do?
-
Excess plasmin protease can also cleave circulating fibrinogen
(fibrinogenlysis) and produces undesirable bleeding.
- what is the diff between SK and tPA? tissue plasminogen activator and streptokinase
-
tPA is relatively selective for the clot-associated fibrin bound
plasminogen, rather than the circulating plasminogen, and hence
less likely to release a large amount of circulating plasmin and
causing systemic fibrinogenolysis.
- what are some absolute contraindications of thrombolytic drugs
- Suspected aortic dissection, active internal bleeding or uncontrollable external bleeding (excluding menses), recent head trauma (< 2 weeks), intracranial neoplasms, history of proven hemorrhagic stroke or cerebral infarction with 12 months, untreated diabetic hemorrhagic / proliferative retinopathy, uncontrolled BP (>180/110 mmHg), etc. 2>
- what does alpha-2 - antiplasmin do
-
inhibition of fbrinolysis
- what does amicar (aminocaproic acid) do?
-
a lysine analog that compeetes for lys binding sites on plasminogen and plasmin thus blocking the interaction with plasmin with fibrin
inhibition of fibrinolysis - what are two inhibitors of tPA?
- plasminogen activator 1 and 2
-
LO from the ITO
discuss the principles and role of thrombosis in the pathogenesis of acute coronary syndrome (ACS)
- ... see ppt
-
ITO LO
discuss the endogenous anti-thrombotic mechanisms and pathogenesis of coronary thrombosis
- hope u know this
-
discuss the strategies and gasic pharmacology of the fibrinolytic drugs
discuss the basic pharmacology of the anti-platelet drugs
- this is a LO from the ITO